Effect of Dietary Sodium Intake on Vascular Endothelium



Status:Active, not recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 60
Updated:4/6/2019
Start Date:April 2012
End Date:December 2019

Use our guide to learn which trials are right for you!

A Pilot Study of the Effect of Dietary Sodium Intake on Assessments of Vascular Endothelium

The investigators will test the hypothesis that markers of vascular endothelial dysfunction
will be exaggerated acutely with an extreme high sodium diet compared to an extreme
low-sodium diet. The investigators will compare patients with postural orthostatic
tachycardia (POTS) to healthy control subjects.

The study will involve a crossover design in which each subject will be assessed (as below)
while on a very low-sodium (10 mEq/day) diet compared with a very high-sodium diet. These
acute dietary interventions will be part of the parent study ("Dietary Salt in Postural
Tachcyardia Syndrome" funded by R01 HL102387) for 4-5 days at the time of the study. Dietary
success will be assessed using a 24h urine for sodium and creatinine as a part of the parent
study.

Blood will be drawn and collected in a fasting state for future assay and analysis of the
following tests:

- Glucose, Insulin (glucose impairment, insulin resistance)

- Fasting lipid profile

- C-Reactive Protein (hsCRP) (inflammatory state)

- Inflammatory cytokines (inflammatory state)

- aliquots (future analysis)

Pulsitile Arterial Tonometry (PAT) Protocol Calf Blood Flow in Reactive Hyperemia (CBF-RH) -
venous occlusion plethysmography Evaluation of Forearm-Mediated Dilation

Inclusion Criteria:

- Subjects will be enrolled in the parent study "Dietary Salt in Postural Tachcyardia
Syndrome" funded by R01 HL102387 Postural Tachycardia Syndrome

- Diagnosed with postural tachycardia syndrome by the Vanderbilt Autonomic Dysfunction
Center

- Subjects will be enrolled in the parent study "Dietary Salt in Postural Tachcyardia
Syndrome" funded by R01 HL102387

- Postural Tachycardia Syndrome

- Diagnosed with postural tachycardia syndrome by the Vanderbilt Autonomic Dysfunction
Center

- Increase in heart rate ≥30 beats/min with position change from supine to standing (10
minutes)

- Chronic symptoms consistent with POTS that are worse when upright and get better with
recumbence Control Subjects

- Healthy, non-obese, non-smokers without orthostatic tachycardia

- Selected to match profiles of POTS patients (gender, age)

- Not using vasoactive medication

- Age between 18-60 years

- Male and female subjects are eligible.

- Able and willing to provide informed consent

Exclusion Criteria:

- Overt cause for postural tachycardia (such as acute dehydration)

- Inability to give, or withdrawal of, informed consent

- Pregnant

- Other factors which in the investigator's opinion would prevent the subject from
completing the protocol.
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Satish Raj, MD, MSCI
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials